Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Net Receivables

₹124.42B

Quarterly · Period ending: · INR

RDY logo

RDY Net Receivables

Latest reported₹124.42B INR
RDY Quarterly Net Receivables · INR (₹2.63B → ₹124.42B)
High-resolution chart · PNG

RDY net receivables history

Quarterly · INR. Dates are reporting period ends; fiscal years can differ from calendar years.

Dr. Reddy's Laboratories Ltd Common Stock Net Receivables — Quarterly (INR)
Period endingNet Receivables (INR)
124,417,000,000
99,215,136,000
124,269,000,000
120,841,000,000
115,443,000,000
109,792,000,000
111,494,000,000
102,840,000,000
81,088,000,000
95,338,000,000
1,018,305,268
89,693,000,000
77,248,000,000
83,203,000,000
934,824,126
984,029,132
974,453,132
1,059,320,356
887,958,873
967,094,405
854,688,551
716,499,974
754,672,049
708,633,776
649,888,250
816,298,474
663,984,706
40,698,000,000
37,845,000,000
46,630,000,000
37,192,000,000
46,135,000,000
47,927,000,000
50,200,000,000
42,432,000,000
42,203,000,000
41,140,000,000
45,737,000,000
41,119,000,000
36,939,000,000
35,499,000,000
48,604,000,000
41,904,000,000
42,840,000,000
42,030,000,000
48,595,000,000
40,224,000,000
37,722,000,000
36,110,000,000
41,022,000,000
34,812,000,000
33,291,000,000
29,168,000,000
38,548,000,000
26,873,000,000
26,755,000,000
25,406,000,000
30,037,000,000
27,039,000,000
21,243,000,000
17,614,000,000
22,441,000,000
20,857,000,000
13,376,000,000
275,000,000
15,793,000,000
16,897,000,000
18,417,000,000
280,000,000
19,658,000,000
12,910,000,000
10,375,245,000
13,750,264,000
6,896,240,000
7,768,057,468
8,546,677,736
7,139,813,012
7,682,118,130
6,043,725,923
9,827,817,000
9,667,647,471
4,814,187,852
4,511,940,000
4,357,083,016
3,932,869,486
3,587,292,389
3,714,565,143
4,092,706,454
4,164,515,000
3,760,694,321
4,149,954,296
4,226,910,719
4,182,325,769
3,609,621,239
3,825,803,301
3,790,000,098
3,567,134,330
3,825,996,098
3,920,626,417
4,441,381,534
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.